EDAP TMS SA (EDAP)
3.415
+0.02
(+0.44%)
USD |
NASDAQ |
Apr 08, 16:00
3.415
0.00 (0.00%)
After-Hours: 18:28
EDAP TMS EPS Diluted (Quarterly) : -0.2523 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -1.170 |
| Cellectis SA | -0.2621 |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0461 |
| Akari Therapeutics Plc | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.449M |
| Revenue (Quarterly) | 21.86M |
| Total Expenses (Quarterly) | 31.31M |
| Enterprise Value | 134.67M |
| Gross Profit Margin (Quarterly) | 42.58% |
| Profit Margin (Quarterly) | -43.22% |
| Earnings Yield | -23.17% |
| Normalized Earnings Yield | -23.17 |